- Home
- APVO vs GIGM Comparison
APVO vs GIGM Comparison
Compare APVO & GIGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- GIGM
- Stock Information
- Founded
- APVO 2016
- GIGM 1998
- Country
- APVO United States
- GIGM Taiwan
- Employees
- APVO N/A
- GIGM N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- GIGM Computer Software: Programming Data Processing
- Sector
- APVO Health Care
- GIGM Technology
- Exchange
- APVO Nasdaq
- GIGM Nasdaq
- Market Cap
- APVO 21.7M
- GIGM 17.8M
- IPO Year
- APVO N/A
- GIGM 2000
- Fundamental
- Price
- APVO $1.09
- GIGM $1.52
- Analyst Decision
- APVO
- GIGM
- Analyst Count
- APVO 0
- GIGM 0
- Target Price
- APVO N/A
- GIGM N/A
- AVG Volume (30 Days)
- APVO 757.7K
- GIGM 5.1K
- Earning Date
- APVO 11-06-2025
- GIGM 10-30-2025
- Dividend Yield
- APVO N/A
- GIGM N/A
- EPS Growth
- APVO N/A
- GIGM N/A
- EPS
- APVO N/A
- GIGM N/A
- Revenue
- APVO N/A
- GIGM $3,397,000.00
- Revenue This Year
- APVO N/A
- GIGM N/A
- Revenue Next Year
- APVO N/A
- GIGM N/A
- P/E Ratio
- APVO N/A
- GIGM N/A
- Revenue Growth
- APVO N/A
- GIGM 10.11
- 52 Week Low
- APVO $1.07
- GIGM $1.38
- 52 Week High
- APVO $298.00
- GIGM $1.89
- Technical
- Relative Strength Index (RSI)
- APVO 27.92
- GIGM 38.46
- Support Level
- APVO $1.39
- GIGM $1.51
- Resistance Level
- APVO $1.54
- GIGM $1.57
- Average True Range (ATR)
- APVO 0.09
- GIGM 0.04
- MACD
- APVO -0.03
- GIGM -0.01
- Stochastic Oscillator
- APVO 3.06
- GIGM 6.67
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About GIGM GigaMedia Limited
GigaMedia Ltd is a diversified provider of digital entertainment services. Its only segment and principal business is digital entertainment service business, which operates a portfolio of digital entertainment products, targeting digital entertainment service users across Asia. It operates digital entertainment business in Taiwan, Hong Kong and Macau through FunTown.